![Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma | SpringerLink Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12035-020-02088-w/MediaObjects/12035_2020_2088_Fig4_HTML.png)
Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma | SpringerLink
![Frontiers | Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway Frontiers | Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway](https://www.frontiersin.org/files/Articles/722754/fonc-11-722754-HTML-r2/image_m/fonc-11-722754-g001.jpg)
Frontiers | Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway
![Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?” - Glynn - 2019 - Cancer Medicine - Wiley Online Library Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?” - Glynn - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/16f3044d-db8a-404b-97cc-cc6cf7ac08d8/cam42398-fig-0003-m.jpg)
Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?” - Glynn - 2019 - Cancer Medicine - Wiley Online Library
![Current Oncology | Free Full-Text | Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Current Oncology | Free Full-Text | Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and](https://www.mdpi.com/curroncol/curroncol-28-00220/article_deploy/html/images/curroncol-28-00220-g004.png)
Current Oncology | Free Full-Text | Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and
![Kaplan-Meier analysis of overall survival in 178 pediatric patients... | Download Scientific Diagram Kaplan-Meier analysis of overall survival in 178 pediatric patients... | Download Scientific Diagram](https://www.researchgate.net/publication/23563338/figure/fig3/AS:277147383025673@1443088493721/Kaplan-Meier-analysis-of-overall-survival-in-178-pediatric-patients-with-glioblastoma.png)
Kaplan-Meier analysis of overall survival in 178 pediatric patients... | Download Scientific Diagram
![Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | Scientific Reports Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-67697-w/MediaObjects/41598_2020_67697_Fig1_HTML.png)
Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | Scientific Reports
![Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway | BMJ Open Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/11/3/e043208/F1.large.jpg)
Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway | BMJ Open
![Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme - eBioMedicine Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme - eBioMedicine](https://www.thelancet.com/cms/attachment/58cecd69-1fcd-4174-b27d-f40096a580ea/gr1_lrg.jpg)
Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme - eBioMedicine
![Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis | Scientific Reports Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-68011-4/MediaObjects/41598_2020_68011_Fig1_HTML.png)
Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis | Scientific Reports
![Frontiers | Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database Frontiers | Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database](https://www.frontiersin.org/files/Articles/659921/fneur-12-659921-HTML/image_m/fneur-12-659921-g001.jpg)
Frontiers | Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database
![Overall survival and progression-free survival among 28 glioblastoma... | Download Scientific Diagram Overall survival and progression-free survival among 28 glioblastoma... | Download Scientific Diagram](https://www.researchgate.net/publication/23192241/figure/fig1/AS:601667074523176@1520460017963/Overall-survival-and-progression-free-survival-among-28-glioblastoma-multiforme-patients.png)
Overall survival and progression-free survival among 28 glioblastoma... | Download Scientific Diagram
![Kaplan-Meier overall survival (OS) curves for recurrent glioblastoma... | Download Scientific Diagram Kaplan-Meier overall survival (OS) curves for recurrent glioblastoma... | Download Scientific Diagram](https://www.researchgate.net/publication/265609405/figure/fig4/AS:316397751160835@1452446510810/Kaplan-Meier-overall-survival-OS-curves-for-recurrent-glioblastoma-multiforme-patients.png)
Kaplan-Meier overall survival (OS) curves for recurrent glioblastoma... | Download Scientific Diagram
![Kaplan-Meier product-limit survival curve of overall survival among all... | Download Scientific Diagram Kaplan-Meier product-limit survival curve of overall survival among all... | Download Scientific Diagram](https://www.researchgate.net/publication/321774931/figure/fig1/AS:571318464909312@1513224344165/Kaplan-Meier-product-limit-survival-curve-of-overall-survival-among-all-patients-with-GBM.png)
Kaplan-Meier product-limit survival curve of overall survival among all... | Download Scientific Diagram
![Five-and 10-year relative survival rates for glioblastoma by age, SEER... | Download Scientific Diagram Five-and 10-year relative survival rates for glioblastoma by age, SEER... | Download Scientific Diagram](https://www.researchgate.net/publication/264163798/figure/fig1/AS:392387055636481@1470563772642/Five-and-10-year-relative-survival-rates-for-glioblastoma-by-age-SEER-18-registries.png)
Five-and 10-year relative survival rates for glioblastoma by age, SEER... | Download Scientific Diagram
![JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme](https://dm5migu4zj3pb.cloudfront.net/manuscripts/138000/138649/medium/JCI138649.f7.jpg)
JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
![Cureus | Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme | Article Cureus | Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme | Article](https://assets.cureus.com/uploads/figure/file/12404/lightbox_23292780142311e79f4c9317245caa8f-Figure1.png)
Cureus | Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme | Article
![Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients | Scientific Reports Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-56574-w/MediaObjects/41598_2019_56574_Fig1_HTML.png)